Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-21 Sale |
2024-05-23 4:17 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
6,703 | $7.811 | $52,357 | 449,092 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-22 4:56 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
6,928 | $8.7463 | $60,594 | 452,795 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-22 5:20 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
4,714 | $4.3622 | $20,563 | 346,973 (Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 4:48 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
4,733 | $3.5518 | $16,811 | 348,687 (Direct) |
View |
| 2023-05-23 Sale |
2023-05-25 08:52 am |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
4,711 | $3.6532 | $17,210 | 353,420 (Direct) |
View |
| 2023-02-21 Sale |
2023-03-02 4:36 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
5,586 | $3.001 | $16,764 | 355,131 (Direct) |
View |
| 2022-11-22 Sale |
2022-11-23 4:15 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
3,456 | $1.949 | $6,736 | 282,717 (Direct) |
View |
| 2022-08-22 Sale |
2022-08-24 5:45 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
3,420 | $0.98363 | $3,364 | 286,173 (Direct) |
View |
| 2022-06-06 Sale |
2022-06-08 8:02 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
43,920 | $0.65059 | $28,574 | 289,593 (Direct) |
View |
| 2022-05-20 Sale |
2022-05-23 4:35 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
3,425 | $0.6714 | $2,300 | 333,513 (Direct) |
View |
| 2022-02-22 Sale |
2022-02-25 4:54 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
3,400 | $0.67 | $2,278 | 333,938 (Direct) |
View |
| 2021-11-22 Sale |
2021-11-24 4:08 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
643 | $0.9919 | $638 | 197,030 (Direct) |
View |
| 2021-08-20 Sale |
2021-08-24 6:07 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
630 | $1.32 | $832 | 44,673 (Direct) |
View |
| 2021-05-20 Sale |
2021-05-21 4:49 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
611 | $7.0878 | $4,331 | 45,303 (Direct) |
View |
| 2021-02-22 Sale |
2021-02-24 4:40 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
611 | $6.8825 | $4,205 | 45,914 (Direct) |
View |
| 2020-09-16 Sale |
2020-09-17 6:35 pm |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
6,087 | $6.1055 | $37,164 | 13,913 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-31 Option Award(A) |
2025-02-04 5:27 pm |
N/A 2035-01-31 |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
53,850 | $0 | 123,080 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:33 am |
N/A 2035-01-30 |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
35,900 | $1.73 | 123,080 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:33 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
17,950 | $0 | 123,080 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-20 5:00 pm |
N/A N/A |
Veradigm Inc. | MDRX | Rodriguez Susan Director |
42,106 | $0 | 42,106 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 9:04 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
97,633 | $0 | 152,915 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 4:37 pm |
N/A 2034-01-16 |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
257,750 | $0 | 604,723 (Direct) |
View |
Ownership |
2023-02-27 5:27 pm |
N/A N/A |
Veradigm Inc. | MDRX | Rodriguez Susan Director |
0 | $0 | 0 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-06 4:24 pm |
N/A 2033-01-05 |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
429,000 | $0 | 711,717 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 5:21 pm |
N/A 2032-12-16 |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
115,740 | $0 | 132,442 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-12 7:47 pm |
N/A 2032-01-06 |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
336,000 | $0 | 533,031 (Direct) |
View |
| 2021-12-22 Option Award |
2021-12-23 6:58 pm |
N/A 2031-12-22 |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
31,355 | $0 | 37,605 (Direct) |
View |
| 2021-10-08 Option Award |
2021-10-29 7:56 pm |
N/A N/A |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
150,000 | $0 | 197,673 (Direct) |
View |
Ownership |
2021-09-29 4:18 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
0 | $0 | 43,750 (Direct) |
View |
| 2021-01-05 Option Award |
2021-01-07 7:11 pm |
N/A 2031-01-05 |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
179,367 | $0 | 193,280 (Direct) |
View |
| 2020-05-18 Option Award |
2020-05-20 5:47 pm |
N/A 2030-05-18 |
ARDELYX INC. | ARDX | Rodriguez Susan Chief Commercial Officer |
252,750 | $0 | 252,750 (Direct) |
View |